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Background: There is a major gradient in burden of disease between Central and Eastern Europe compared to
Western Europe. Many of the underlying causes and risk factors are amenable to public health interventions. The
purpose of the study was to explore perceptions of public health experts from Central and Eastern European
countries on public health challenges in their countries.
Methods: We invited 179 public health experts from Central and Eastern European countries to a 2-day workshop
in Berlin, Germany. A total of 25 public health experts from 14 countries participated in May 2008. The workshop
was structured into 8 sessions of 1.5 hours each, with the topic areas covering coronary heart disease, stroke,
prevention, obesity, alcohol, tobacco, tuberculosis, and HIV/AIDS. The workshop was recorded and the proceedings
transcribed verbatim. The transcripts were entered into atlas.ti for content analysis and coded according to the
session headings. After analysis of the content of each session discussion, a re-coding of the discussions took place
based on the themes that emerged from the analysis.
Results: Themes discussed recurred across disease entities and sessions. Major themes were the relationship
between clinical medicine and public health, the need for public health funding, and the problems of proving the
effectiveness of disease prevention. Areas for action identified included the need to engage with the public, to
create a better scientific basis for public health interventions, to identify “best practices” of disease prevention, and
to implement registries/surveillance instruments. The need for improved data collection was seen throughout all
areas discussed, as was the need to harmonize data across countries.
Conclusions: To reduce the burden of disease across Europe, closer collaboration of countries across Europe seems
important in order to learn from each other. A more credible scientific basis for effective public health interventions
is urgently needed. The monitoring of health trends is crucial to evaluate the impact of public health programmes.Background
Within Europe, there is a gradient in life expectancy be-
tween Western European countries and Central and East-
ern European countries [1]. In 2009, life expectancy was 81
years of age in the Western European Union member states
before 2004 compared to 75 years of age in the Central and
Eastern European member states since 2004 and 2007
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distribution, and reproduction in any mediumLithuania, Romania, Bulgaria). The difference in life expect-
ancy is in particular due to a higher mortality from cardio-
vascular diseases, alcohol-related diseases and injuries in
Central and Eastern European countries compared to
Western European countries [2,3]. Although life expect-
ancy in the Central and Eastern European countries has
been increasing– mainly due to a decrease in cardiovascu-
lar mortality - from 71 years in 1989/90 to 75 years in
2009, the gradient within Europe still persists [1,4,5].
In the European Health Report 2005, the World Health
Organization (WHO) had identified seven leading risk fac-
tors – high blood pressure, tobacco use, harmful and haz-
ardous alcohol use, high cholesterol, being overweight, low
fruit and vegetable intake, and physical inactivity - as being
responsible for the differences in mortality betweend Central Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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et al. named these (vascular) risk factors among the main
contributors for the gradient in mortality between Western
European countries and Eastern and Central European
countries, in addition to road traffic injuries [7]. As they
are amenable to prevention, preventive and public health
programmes have an enormous potential for reducing the
burden of disease in Central and Eastern Europe.
Public health responses to health threats, however,
may differ between and within European countries [8,9].
The concept and role of public health, also in relation to
clinical medicine, have been an issue for debate in many
countries. In a project funded by the European Union,
the role and key functions of public health as perceived
by experts from Central and Eastern European countries
prior to their accession to the European Union showed
some consistencies with those of Europe as a whole
[9,10]. The management of healthcare services, however,
was less likely to be seen as a public health function,
compared to other public health functions such as health
protection, prevention of ill health, or monitoring of
population health [9]. The objective of the present quali-
tative study was to further explore current public health
challenges as perceived by experts from Central and
Eastern European countries, along predefined topics
such as cardiovascular diseases, risk factors amenable to
prevention, as well as tuberculosis and HIV/AIDS.Methods
The workshop was conducted in May 2008 at the
Charité University Medical Center, Berlin, Germany. Other
methods such as an electronic Delphi method or elite
interviews could have been used to explore public health
challenges. However, we wanted to gain information
based on an exchange of thoughts and creative ideas
among public health experts. We used the method of
purposive sampling to gain insight into a wide range of
experiences and perceptions of public health experts
from various Central and Eastern European countries as
well as with different professional affiliations (univer-
sities, public administration including health ministries,
non-governmental organizations). Our sampling process
was based on recommendations and personal contacts of
the planning group (JMN, PT, JP, BR, TU). Overall, we
invited 179 public health experts from Europe with a
total of 25 public health experts from 14 countries finally
participating in the workshop. Countries represented
were Bulgaria, Bosnia and Herzegovina, Croatia, Czech
Republic, Estonia, Germany, Lithuania, Macedonia, Poland,
Romania, Serbia, Slovakia, Slovenia, and the United
Kingdom. Of the 25 workshop participants, 13 (52%)
worked in universities, 10 (40%) in public administration,
and 2 (8%) in non-governmental organisations. Table 1shows basic characteristics of workshop participants com-
pared to all invited public health experts.
Structure of the workshop
The 2-day workshop was conducted in English and
structured into eight sessions lasting on average 1.5
hours each. We chose the following topics for the ses-
sions: coronary heart disease, stroke, prevention, obesity,
alcohol, tobacco, tuberculosis, and HIV/AIDS. We
decided to focus on certain diseases and risk factors as
well as on prevention as a broader topic, also with regard
to the limited time available. The selection was based on
personal expertise and interests of the planning group
members. Other important public health needs and
topics, for example cancer, mental health problems, or
injuries were not included in the workshop. Also, public
health areas such as health services provision or health
economics were not allocated separated sessions. They
were therefore only discussed in the context of specific
diseases.
Two chairpersons out of the public health experts
from the workshop chaired each session on a rotation
base. A short presentation (5–10 minutes) on the topic
was given at the beginning of each session to stimulate
discussion. The structure of the sessions recommended
to the respective chairpersons was based on the method
of the ‘Six Thinking Hats’ developed by Edward de Bono
[11]. However, in most sessions the moderators did not
follow the predefined structure but instead allowed for
free and lively discussions after the initial presentation.
Qualitative analysis
The discussions of the workshop were recorded and the
proceedings transcribed verbatim. The transcripts were
entered into atlas.ti for content analysis. In a first step, a
coding of all text took place along the thematic issues.
The coded segments were then divided into statements
about the status quo, existing problems and research
questions, and a country code assigned to all segments.
Following this, we conducted an in-depth analysis of the
major issues arising within the broad themes and devel-
oped new codes. All materials were then re-coded using
the code list developed. Coding was independently con-
ducted by two investigators. The final code list was dis-
cussed in the research group. A comparison of the code
list across thematic codes revealed a list of conceptual
issues that proved pertinent across all topics. These con-
cepts were used for the final work-up of the material.
Occasionally, quotations had to be edited for readability,
taking into account that for most participants of the work-
shop English was not their native language. The person re-
sponsible for data analysis (CH) did not have access to any
personal data of the participants and was not present at
the workshop herself. To ensure anonymity for the quotes,
Table 1 Basic characteristics of invited public health
experts and workshop participants [in brackets]
University Public
administration
NGO* All
Albania 2 2
Bulgaria 6 [1] 2 1 [1] 9 [2]
Bosnia &
Herzegovina
1 [1] 6 4 11 [1]
Croatia 6 3 [1] 9 [1]
Czech Republic 3 [1] 7 [1] 3 13 [2]
Estonia 6 7 [1] 2 15 [1]
Germany 4 [4] 3 [3] 7 [7]
Hungary 1 7 3 11
Latvia 8 2 10
Lithuania 6 3 [1] 9 [1]
Macedonia 4 1 4 [1] 9 [1]
Montenegro 5 5
Poland 11 1 [1] 12 [1]
Romania 14 [2] 12 [1] 26 [3]
Serbia 8 [1] 1 9 [1]
Slovakia 1 9 [1] 1 11 [1]
Slovenia 3 [1] 5 1 9 [1]
United Kingdom 2 [2] 2 [2]
All 78 [13] 80 [10] 21 [2] 179 [25]
*NGO=Non-Governmental Organisation.
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age in quotes cited in this text. Participants were informed
a priori about the recording and subsequent analysis and
provided verbal consent.Results
The themes that proved important across the spectrum
of topics discussed were the relationship between clinical
medicine and public health, the need for public health
funding, and the challenge of proving the effectiveness of
disease prevention. In light of the latter, a need for
improved data collection was identified throughout all
areas discussed, as was a need to harmonize data across
countries. Finally, our analysis identified areas for action
that were perceived as crucial for strengthening public
health in Central and Eastern Europe.
Underlying all discussions was a general understanding
of the workshop participants that the main tasks of pub-
lic health were to reduce risky behaviours (risk factors)
in society and to prevent diseases. The general consensus
was that national and supranational political will was es-
sential to implement public health efforts and to reach
set goals, making it a pre-requisite for effective public
health interventions. Themes discussed recurred across
disease entities and sessions.Clinical medicine and public health
An important theme throughout the discussions was the
relationship between clinical medicine and public health.
Prevention programmes were perceived as being often
headed by medical professionals in clinical fields. Since
clinical medicine and public health have different per-
spectives and medicine itself is diversified, conflicts were
seen to arise easily (Table 2, Quote 1a).
Clinical medicine seemed the more powerful of the
siblings. Its research may be influenced by industry inter-
ests and, in most countries, the social prestige and in-
come of clinicians is higher than that of public health
workers. Workshop participants perceived it as insuffi-
cient to allocate a certain amount of the time of health
professionals to prevention efforts, without defining this
more precisely (Table 2, Quote 1b).
In some countries the interplay between clinical medi-
cine, public health and prevention was perceived as
working extremely well. To achieve this, political will
was thought to be as important as the willingness of dif-
ferent professions to collaborate on common goals
(Table 2, Quote 1c).
Overall, the perception among the workshop partici-
pants was that clinical medicine and public health pro-
grammes are competing for funds. Results of clinical
research are regularly celebrated as breakthroughs, which
may be one of the reasons why political support for pub-
lic health is weaker than for clinical medicine and bio-
medical research (Table 2, Quote 1d).
The pharmaceutical industry was perceived to play an
important role in the predominance of clinical medicine,
as it earns a lot of money through clinical approaches,
but hardly anything from most public health measures
(Table 2, Quote 1e).
Need for increased public health funding
The workshop participants could not identify ‘natural’
forces that exist to bring the public health agenda to the
forefront of funding. However, the group agreed that
there was a definite need for increased funding of public
health activity in Central and Eastern Europe. Particu-
larly, the breakdown of the former political and eco-
nomic system was described as resulting in significant
health risks, as it introduced a myriad of lifestyle
changes, such as an increase in alcohol consumption in
some countries and the increasing availability of ‘junk
food’ (Table 2, Quote 2a).
Apart from lifestyle changes, there was also a breakdown
of the often well-functioning public health infrastructures,
such as cancer registries, screening programmes, and the
surveillance of infectious diseases such as tuberculosis
(Table 2, Quote 2b).
Accession to the European Union was perceived as
offering new opportunities for strengthening public
Table 2 Themes of workshop discussions – direct quotations
Key Direct quotation Session
1. Clinical medicine and public health
1a “(. . .) it is widely assumed that stroke prevention is the domain of neurologists. Neurologists, unlike cardiologists, do
not have a strong tradition of involvement with epidemiology and prevention. I think that if you have a situation
where stroke is seen as the domain of neurologists this can create major problems in terms of lack of professional
leadership for prevention programmes in relation to stroke.”
Stroke
1b “In our health care law there is one sentence that says about 30% of all day work for all health professionals has to
be related to prevention. It is a very good sentence but this is not how it is done. One problem is how they’re going
to fill in some kind of report and the other problem is how they are going to be paid.”
Prevention
1c “Okay, I just want to tell you one very interesting positive aspect. For example we have managed to get prevention
into the political agenda quite well I think. For example in the coalition agreement of our government it is said that
each year at least a certain amount of money has to go to prevention programmes. And I think it’s good. And
the second example we have is a round table which is formed by representatives of the ministry, the hospital
association, the physician association, the nursing association etc. and we’re discussing health financing in our
country. And for example the representative of the physician association is insisting all the time that you have to raise
money for prevention; you can’t cut any budget from prevention.”
Prevention
1d “Our health politicians agree that cardiovascular diseases are a priority. But the problem is that curative health is much
more powerful than public health. And when we’re discussing allocation of resources curative health wins. And now
we’re discussing 2007–2030 and the problem is that cardiovascular disease is agreed on as one of most serious issues,
but all this money will be allocated to hospital renovations, to equipment, but not for human capital and it’s very
important I think to convince health politicians that public health actions are cost-effective.”
Cardiovascular
diseases
1e “(. . .) how can we balance public health policy regarding lifestyle changes vis-á-vis medical intervention? Now medical
intervention of course has the industry as a strong driver, whereas in public health policy the drivers are
much weaker in a way. You know, it’s not very fashionable to make public health policy even as a politician,
it’s very fashionable to make policy on say family issues. Maybe defence issues. Maybe security issues, but public
health usually doesn’t have a very high reputation even among politicians.”
Cardiovascular
diseases
2. The need for increased public health funding
2a “I know that capitalism brought us after 1990 very good things but also some problems with food. Because the
invasion of new products, very well presented, and also no food control brought us some behaviour not very
good for our family and also the children.”
Obesity
2b “(. . .) but after the Second World War we had a good performance, an acceptable level of prevalence [of TB].
Because everything was mandatory at that time, it was maybe better for TB. After 1990 the democracy brought the
problem for us. The surveillance for TB after 1990 was non-existent.”
Infectious diseases
2c “(. . .) like the countries that already joined the EU, in our country there is a very favourable political climate to push
different solutions, especially if they’re in line with the EU directives (. . .) and in such a way we could be pushing
forward some effective policies.”
Stroke
3. Effectiveness of prevention
3a “I wanted to raise the question about the effectiveness of the prevention measures. And I would say that we really
don’t have data about whether the preventive activity is working or not.”
Prevention
3b “I do agree [. . .] that prevention is important, we should do it, it’s probably cost-effective etcetera etcetera.
But I think we haven’t really been able to clearly define or show the effectiveness in studies what is effective
and how it is effective.”
Obesity
3c “I suggest that we should find ways how to evaluate the effectiveness of the preventive measures we are
undertaking. (. . .) This would be a way to convince politicians and the public and also experts from other
professional fields that our proposal is really the best one and that it should be adopted.”
Prevention
4. Data harmonisation across Europe
4a “[In some countries] of course the best data regarding stroke are mortality data. But then I recently realised
that ‘stroke’ is a difficult diagnosis. There are no international criteria for diagnosing stroke. So it looks like
different hospitals diagnose stroke a little bit differently. That’s the weakness of the data. Strokes are not
comparable even between hospitals, let alone between regions in the country.”
Stroke
4b “(. . .) I support the view that hospital data will not be terribly useful, certainly not [in some countries]. We found
that in the rural area sixty percent of strokes in elderly women were not admitted to hospital. Younger men, yes,
strokes in younger men, yes, but older women, no, older rural women, especially no.”
Stroke
Abbreviation: Tb = Tuberculosis.
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public health interventions could be improved by follow-
ing European directives (Table 2, Quote 2c).Lobbying was seen as crucial to ensure a higher visibility
and funding of public health efforts. Especially the local
constituency was mentioned as a valuable source to
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tioned the use of elections. In election times, many pro-
grammes may get funded that otherwise go unnoticed.
Similarly, coalition-building with individual politicians was
mentioned. In line with lobbying with local constituencies,
a “bottom-up” approach was discussed as a possible avenue
to initiate change.
Effectiveness of prevention
A theme discussed throughout the disease spectrum was
the effectiveness of prevention efforts. Most participants
believed that there was very limited data on effective
interventions (Table 2, Quote 3a and b).
One of the most important points brought up during
the workshop was that funds need to be made available for
well-designed evaluations of public health interventions.
This would also help to build public health research cap-
acity. The group believed that if the effectiveness of pre-
vention efforts were proven, political and public support
would be easier to achieve (Table 2, Quote 3c).
Data harmonisation across Europe
Many participants pointed out that comparable informa-
tion on disease and risk factor trends in Europe was lim-
ited, and that this hindered the coordination of public
health programmes across countries. At the same time,
creating comparable surveillance data was recognised as
being difficult, as diagnosing techniques may differ
across countries (Table 2, Quote 4a)
Collecting high-quality data was further complicated
through different treatment facilities and traditions. In
some countries, diseases like stroke may be treated in
hospitals, while in others they were treated in local
health facilities. This may even differ from region to re-
gion in a single country (Table 2, Quote 4b).
Developing comparable data for Europe will require
careful consideration of how, where and by whom data
should be collected in each country and region. This will
necessitate an understanding of local health care prac-
tices within and across countries.
Areas of public health action in Europe
Throughout the discussions, group members mentioned
areas for action that they found most pressing for public
health in Europe. Table 3 subsumes activities and goals
of the four areas for action identified (Table 3).
Discussion
Major themes discussed were the relationship between
clinical medicine and public health, the need for public
health funding, and the problems of proving the effect-
iveness of disease prevention. The need for improved
data collection and harmonization was seen throughout
all themes discussed.Clinical medicine and public health funding
The relationship between clinical medicine and public
health appeared to work well in some countries, whereas
public health experts from other countries reported an
unequal relationship. Clinical medicine was generally
regarded as the stronger partner, particularly with regard
to funding and available resources. According to the
Organization for Economic Co-operation and Develop-
ment (OECD), expenditure on organised public health
and prevention programmes ranged between 2.3% of
total expenditure on health in the Czech Republic and
5.0% in the Slovak Republic in 2007 [12]. The percentage
of total expenditure Central and Eastern European coun-
tries were willing to allocate to public health and preven-
tion was similar to Western European countries.
However, total expenditure on health per capita varied
largely between countries and was approximately 70%
higher in Western Europe compared to Central and
Eastern Europe. In addition, the researchers of the
SPHERE (Strengthening Public Health Research in Europe)
project showed a marked variation in the amount of public
health publications by country in Europe [13]. Eastern and
Southern European countries appeared to under-invest in
public health research compared with Northern European
countries. Taking into account the higher burden of dis-
eases amenable to public health and prevention in Central
and East Europe, there seems to be an inverse relationship
between available resources and need for public health and
prevention within Europe even when considering differ-
ences in programme costs.
Effectiveness of prevention
The workshop discussions suggested that empirical data
on the effectiveness of preventive and public health pro-
grammes are lacking in many countries. The SPHERE
project yielded a similar perception among public health
experts in Europe [14]. In comparison to clinical inter-
ventions, the evaluation of preventive programmes has
been less rigorously conducted throughout the last dec-
ades in most countries. Preventive programmes are often
multi-faceted and dependent on the socio-cultural envir-
onment rendering their evaluation and the comparison
across different settings challenging. Some databases
such as the Canadian Task Force on Preventive Health
Care, the U.S. Preventive Services Task Force and the
Cochrane Public Health Group summarise the existing
evidence on prevention, however, the transferability of
the results to Central and Eastern European countries
remains to be assessed [15-17]. Measures to timely adapt
and re-evaluate effective programmes particularly in
countries with fewer resources need to be developed.
Closely linked to the principles of evidence-based pre-
vention is the concept of ‘best practice’ [18]. During the
workshop, participants repeatedly suggested identifying
Table 3 Areas for public health action in Europe
Activities Goals
1. Engaging the public
- To raise public awareness about public health and its significance - Stronger public health policy
- To create a large public lobbying body for healthy
behaviour through sophisticated social marketing strategies
- Stronger public health funding
2. Creating a scientific base for public health
- To conduct cost-effectiveness studies - Proof of the effectiveness of public health for the public good
- To create public database for all on-going public health related-research
- To conduct large scale studies
3. Developing best practice interventions
- To ensure adequate funding for studies - Facilitation of best possible public health interventions
- To allocate evaluation funds in every study - Development of good public health practice and research
4. Implementing registries and surveillance systems
- To implement registries for infectious diseases - Preparation for new pandemics
- To implement alert systems for increase in imported
infectious diseases
- Preparation for changing disease patterns due to changing living
and travel conditions
- To train physicians accordingly
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such as the California Tobacco Control Program in the
United States [19]. A European database on effective pre-
vention, including examples of ‘best practice’ and results
of country-specific programmes, would be a valuable tool
for decision-making.
Need for data harmonisation and accessibility across
Europe
Workshop participants emphasized the urgent need for
data harmonisation and standardised data collections
across Europe. The Regional Office for Europe of the
World Health Organization (WHO), similarly, states that
health data – health indicators and statistics - are essen-
tial for monitoring trends in health and evaluating the
impact of public health policies and programmes [20].
The European Parliament and the Council have also
recognised the need to systematically collect, process
and analyse comparable data for an effective monitoring
of the state of health in the European Union [21]. Regional
and time comparisons of health data have often been
based on studies using different definitions and assessment
methods and are thus of limited validity. Existing data
needs to be adapted whereas new data collection should
be performed using standardised assessment methods. The
European Community Health Indicators’ (ECHI) project,
for example, has aimed at providing a frame for compar-
able data collection in the public health area in Europe
[22]. The availability of health indicators varies between
regions with Central and Eastern European countries hav-
ing less available data on morbidity and risk factors com-
pared to Western European countries [23]. Funding isrequired to fulfil the request for data harmonisation in
Europe, particularly with regard to countries with lower
resources at their disposal. In addition to the quality of the
underlying health data, the accessibility of the data by pub-
lic health experts needs to be improved. Although data-
bases such as the ‘Health for All Database’ of the WHO
Regional Office for Europe [1] are valuable tools, the var-
iety of existing databases seems to be a hindrance for their
day-to-day use. A one-in-all database combining data from
the respective sources with a user-friendly surface might
be the solution.
Engaging the public
Engaging the public was perceived by our workshop par-
ticipants as a way to influence policy. Good scientific evi-
dence is often insufficient to convince policy-makers to
implement and finance prevention efforts [24]. Policy-
making usually happens quickly and builds on general-
ized knowledge and demands from key stakeholders.
Commercial interests routinely use marketing and lobby-
ing strategies to influence both the public and health
policy makers [25,26]. As health professionals may even
themselves become the target of attacks [27], professional
training in marketing and lobbying may be needed.
Public health in Central and Eastern European countries
Overall, the themes and challenges of public health identi-
fied by the experts from Central and Eastern European
countries in our workshop did not appear to differ to large
extent from those of Europe as a whole [9,10]. The main
tasks of public health were considered to be the reduction
of risky behaviours (risk factors) in society and to prevent
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choice of topics for the workshop with a focus on risk fac-
tors and prevention. However, a survey among experts
from Central and Eastern European countries yielded simi-
lar results, albeit with some differences between countries
[9]. In Estonia, for example, the emphasis appeared to be
on ‘health protection’ (environmental health, communic-
able disease control, immunization). In other countries,
the role of public health was seen in ‘personal hygiene edu-
cation’. Only the experts from Slovenia and Romania
included management of healthcare services as a public
health function. Potential barriers to the provision of ef-
fective public health in Central and Eastern European
countries reported in our workshop appear to be similar to
those observed in most Western European countries. Simi-
larly to our workshop analysis, a qualitative study con-
ducted in Bulgaria identified insufficient institutional,
political and financial support, the dearth of local epi-
demiological data as well as the lack of public health cap-
acity as problems [28]. Specific issues explored for Central
and Eastern European countries were, however, the
increased culture of consumption and in particular the
increased availability of unhealthy diets such as fast food.
Limitations
In this qualitative study, we used purposive sampling to
get a wide range of perspectives and experiences [29].
The generalisability of our results is thus limited as it is
by nature a non-randomly selected and non-representa-
tive sample. In addition, a total of 25 out of the invited
179 public health experts (14%) participated with a lack of
representatives from countries such as Albania, Hungary,
Montenegro, or Latvia. Budgetary reasons or time con-
straints might have been underlying reasons for non-
participation. In our workshop, most participants were
senior public health experts and many of them had a med-
ical and/or other doctoral degree; some of our participants
have studied or worked abroad in international networks.
They might thus differ from the majority of public health
experts in their country. Over the last two decades, public
health education in Central and Eastern Europe has shifted
its focus from hygienic and sanitary measures to a broader
concept of public health [30]. Our participants appeared to
be more representative of these ‘newer’ concepts. Further
research may include a mixed-methods approach combin-
ing qualitative with quantitative data. However, the lack of
a licensing or registration system for public health experts
in European countries certainly is a hindrance to deter-
mining representativeness.
In addition, we chose a predefined set of topics for the
workshop sessions. Other topics with public health im-
portance could be not included, mainly because of the
time available. For example, researchers of the SPHERE
project performed surveys among public health expertsabout research priorities in 12 European countries [14].
Research priorities among survey participants from Eastern
European countries included cardiovascular diseases and
mental health as well as food safety and nutrition,
environmental health and occupational health.
Conclusions
Our findings point to a number of ways in which public
health in Central and Eastern Europe could be strength-
ened. Close collaboration across Europe is important, as
learning from each other seems crucial to reduce health
inequalities within Europe. More efforts are particularly
needed to document public health interventions and to
identify examples of best practice. This will help to address
the political challenges of strengthening public health in
Central and Eastern Europe, in particular in the context of
the current economic crisis.
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